Sigvotatug is a fully human IgG1 kappa monoclonal antibody targeting integrin beta6 (ITGB6). It can serve as the antibody component in the development of Sigvotatug vedotin, an antibody-drug conjugate (ADC) designed to selectively target integrin alphavbeta6-positive tumor cells through a highly specific, engineered antibody framework.
Purity:
95.00%
CAS Number:
[2764774-90-3]
Target:
Integrin
T9901A-506
* VAT and and shipping costs not included. Errors and price changes excepted
